Skip to Main Content
  • About
    • Staff
    • Board of Directors
    • Member Directory
  • Membership
    • Membership Benefits
    • Membership FAQ
    • Join NEC
  • Issues
    • Diversity & Inclusion
    • Energy & Environment
    • Financial Services
    • Healthcare
    • Higher Education
    • Housing
    • Technology & Innovation
    • Trade
    • Transportation & Infrastructure
    • Partnerships for Talent Pipeline Directory
  • News
  • Events
    • Upcoming Events
    • Past Events
    • 2025 Centennial Celebration
    • Washington Leaders’ Conference
    • Politics & Eggs
    • Inside the Corner Office
    • Rising Stars Network
    • Celebrating 100 Years
      • New England Council Fellows Program
    • Sponsorship Opportunities
  • Contact
  • About
    • Staff
    • Board of Directors
    • Member Directory
  • Membership
    • Membership Benefits
    • Membership FAQ
    • Join NEC
  • Issues
    • Diversity & Inclusion
    • Energy & Environment
    • Financial Services
    • Healthcare
    • Higher Education
    • Housing
    • Technology & Innovation
    • Trade
    • Transportation & Infrastructure
    • Partnerships for Talent Pipeline Directory
  • News
  • Events
    • Upcoming Events
    • Past Events
    • 2025 Centennial Celebration
    • Washington Leaders’ Conference
    • Politics & Eggs
    • Inside the Corner Office
    • Rising Stars Network
    • Celebrating 100 Years
      • New England Council Fellows Program
    • Sponsorship Opportunities
  • Contact

News

Mar 6, 2025Blog | Member News, Healthcare

Eli Lilly and Company announces plans to invest $27B in four new US manufacturing plants

(Photo via MIKE BLAKE/REUTERS)

New England Council member, Eli Lilly and Company, has announced plans to build four new manufacturing plants in the United States. One of the biggest drugmakers in the country, Lilly’s announcement is the latest in a major capital push trend across US companies as the Trump Administration seeks to strengthen domestic manufacturing.

The $27 billion investment is expected to create 3,000 jobs for highly skilled workers – such as engineers, scientists, operations personnel, etc.- and employ 10,000 construction workers. The locations of each of these new sites have yet to be announced. However, the company has stated that it expects the plants to begin making medicines within the next five years. Three of the new sites are intended to produce active pharmaceutical ingredients for its drugs. The fourth new site is slated to produce sterile injectable medicines, such as Lilly’s diabetes drug, Mounjaro.

“Lilly’s optimism about the potential of our pipeline across therapeutic areas – cardiometabolic health, oncology, immunology and neuroscience – drives our unprecedented commitment to our domestic manufacturing build-out. Our confidence positions us to help reinvigorate domestic manufacturing, which will benefit hard-working American families and increase exports of medicines made in the U.S.A,” said Lilly chair and CEO, David A. Ricks.

The New England Council congratulates Eli Lilly on this new venture that will boost US manufacturing.

Read more in the Washington Post and this press release from Lilly.

Council Related News
Read Article Blog | Member News, Higher Education

University of New England announces partnership with Atlantic Hospitality to advance student careers

Read Article Blog | Member News, Higher Education

A study released by the CCIC reveals independent colleges are vital to the state’s economy

Read Article Blog | Member News, Energy & Environment

Unitil and Eversource Announce Water Utility Deals

Read Article Blog | Member News, Technology & Innovation

General Dynamics Electric Boat awarded $12.2 billion contract to boost shipbuilder pay and build two new submarines

Read Article Blog | Member News, Higher Education

New England Board of Higher Education announces $500K in grants to spur growth in prison education programs

View Related News

©2025 New England Council
All rights reserved.

Privacy Policy Website Design by Jackrabbit

Boston Office

98 North Washington Street
Suite 303
Boston, MA 02114

(617) 723-4009

necouncil@newenglandcouncil.com

Washington Office

1411 K Street, NW
Suite 700
Washington, D.C. 20005

(202) 547-0048

necouncil@newenglandcouncil.com

Website Design by Jackrabbit